Philip Morris (PM) director Shlomo Yanai granted 1,119 shares in stock award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Yanai Shlomo reported acquisition or exercise transactions in this Form 4 filing.
Philip Morris International Inc. director Shlomo Yanai reported a stock-based compensation grant rather than an open-market purchase. On May 6, 2026, he received 1,119 shares of common stock at an indicated value of $169.93 per share under the company’s 2017 Stock Compensation Plan for Non-Employee Directors.
Following this grant, Yanai directly holds 10,120 shares. Footnotes state that this total includes 8,281 deferred shares in the same plan, reflecting a 1,361 deferred-share increase tied to the 2026 stock award and 242 deferred shares from dividend reinvestment since the prior reportable transaction on May 7, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Yanai Shlomo
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,119 | $169.93 | $190K |
Holdings After Transaction:
Common Stock — 10,120 shares (Direct, null)
Footnotes (1)
- Shares awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors. The average of the high and low price of Philip Morris International Inc. common stock on May 6, 2026. Includes 8,281 deferred shares held in the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors. This is an increase of 1,361 deferred shares, reflecting the total of the 2026 stock award and 242 deferred shares acquired through the reinvestment of dividends since May 7, 2025, the date of the last reportable transaction.
Key Figures
Shares granted: 1,119 shares
Grant valuation price: $169.93 per share
Total shares after transaction: 10,120 shares
+3 more
6 metrics
Shares granted
1,119 shares
Director stock award on May 6, 2026
Grant valuation price
$169.93 per share
Average of high and low price on May 6, 2026
Total shares after transaction
10,120 shares
Direct holdings following the award
Deferred shares held
8,281 shares
Deferred shares in 2017 Stock Compensation Plan
Increase in deferred shares
1,361 shares
Includes 2026 award and 242 shares from dividend reinvestment
Dividend reinvestment shares
242 shares
Deferred shares from reinvested dividends since May 7, 2025
Key Terms
Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors, deferred shares, reinvestment of dividends, Grant, award, or other acquisition
4 terms
Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors financial
"Shares awarded under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors."
reinvestment of dividends financial
"an increase of 1,361 deferred shares, reflecting the total of the 2026 stock award and 242 deferred shares acquired through the reinvestment of dividends"
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
What did Philip Morris (PM) director Shlomo Yanai report in this Form 4?
Shlomo Yanai reported a stock-based compensation grant, not an open-market trade. He received 1,119 Philip Morris common shares as a director award, increasing his direct holdings to 10,120 shares, including a substantial portion held as deferred shares within the company’s 2017 stock compensation plan.
Was Shlomo Yanai’s Philip Morris (PM) transaction a market buy or sell?
The transaction was a grant or award, not a market buy or sell. The Form 4 uses transaction code “A” for a grant, indicating shares were awarded as compensation under the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors rather than traded on the open market.
How was the value of Shlomo Yanai’s Philip Morris (PM) stock award determined?
The award value per share was set at $169.93, described as the average of the high and low Philip Morris common stock prices on May 6, 2026. This pricing approach is disclosed in the footnotes and is often used for valuing equity compensation grants to directors.